Kansas PBM Reform Law Passes, Aiming to Lower Prescription Drug Costs
Topeka, Kan. – Kansas Governor Laura Kelly signed into law Senate Bill 20, the Kansas Consumer Prescription Protection and Accountability Act, on March 23, 2026, marking a significant step towards regulating pharmacy benefit managers (PBMs) and lowering prescription drug costs for Kansans. The bill passed the Kansas Senate 32-8 and the House of Representatives 104-17.
What Does the New Law Do?
The Kansas Consumer Prescription Protection and Accountability Act addresses several key areas of PBM practices, aiming to increase transparency and fairness within the prescription drug supply chain. Specifically, the law:
- Requires Rebate Pass-Through: Mandates that drug rebates negotiated by PBMs be passed through to health plans, ultimately benefiting patients.
- Bans Spread Pricing: Prohibits the practice of “spread pricing,” where a PBM charges a health plan more for a drug than it reimbursed the pharmacy.
- Ensures Pharmacy Reimbursement Equity: Requires all pharmacies to be reimbursed at the same rate, protecting local pharmacies and patient choice.
- Enhances Department of Insurance Oversight: Provides the Kansas Department of Insurance with the tools necessary to ensure transparency and accountability from PBMs.
Why is This Reform Important?
Kansas Insurance Commissioner Vicki Schmidt emphasized the importance of the legislation, stating, “This week, the Kansas Legislature chose to put patients over politics and profits.” She added that the law will prevent PBMs from negatively impacting patients’ finances, local businesses and rural communities.
Pharmacy benefit managers play a crucial role in managing prescription drug benefits, negotiating prices with drug manufacturers and creating formularies for health plans. But, concerns have grown regarding a lack of transparency in PBM practices and their potential to drive up costs for consumers.
Legislative Roadblocks and Passage
The passage of SB 20 wasn’t without challenges. Reports indicate that Kansas House Speaker faced criticism for attempts to obstruct a vote on the bill, highlighting the political complexities surrounding PBM reform. Despite these efforts, legislators from both parties ultimately supported the measure.
What’s Next?
With the bill now signed into law, the Kansas Department of Insurance will initiate the process of implementing the new regulations. This includes developing rules and guidelines for PBMs to ensure compliance. The impact of the law on prescription drug prices and access to care will be closely monitored in the coming months. A brief of the bill can be found here.
The passage of SB 20 represents a significant victory for consumer advocates and healthcare stakeholders in Kansas, signaling a commitment to greater transparency and affordability in the prescription drug market.
Worth a look